• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    Orexigen Therapeutics, Inc. (OREX)

    -NasdaqGS
    5.01 Up 0.01(0.20%) May 22, 4:00PM EDT
    |After Hours : 5.01 0.00 (0.00%) May 22, 4:25PM EDT
    Add to Portfolio
    Prev Close:5.00
    Open:4.99
    Bid:4.75 x 300
    Ask:N/A
    1y Target Est:11.57
    Beta:2.15
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:4.92 - 5.09
    52wk Range:3.11 - 9.37
    Volume:1,716,994
    Avg Vol (3m):6,097,370
    Market Cap:619.88M
    P/E (ttm):N/A
    EPS (ttm):-0.32
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    OREXUp 0.20%619.88M
    ABTDown 0.63%72.99B
    GSKDown 0.66%109.30B
    RHHBYDown 0.94%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):11.14
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.54
    Quarterly EPS Est (Jun-15) :-0.16
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):0.12

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products in the United States. The company offers Contrave for the treatment of obesity. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback